Shanghai Refreshgene Technology Co., Ltd.
PrivateLast Round
Series B
Dec 30, 2024
Total Funding Raised
$15.14M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Shanghai Refreshgene Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series B round in December 2024.
Shanghai Refreshgene Technology Co., Ltd. is a biotechnology company that develops gene therapy drugs for the treatment of chronic and rare diseases, including ophthalmology, otology, cardiovascular, and tumor-related conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Refreshgene Technology Co., Ltd. Comparables
Compare Shanghai Refreshgene Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exegenesis Bio | 86% | |
| Frontera Therapeutics | 85% | |
| Neurophth | 85% |
For institutional investors. Book with your work email.
Shanghai Refreshgene Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 30, 2024 | ||||
| Early Funding | Apr 28, 2023 | ||||
| Series A Extension | Sep 16, 2021 | ||||
| Series A | Nov 2, 2020 | ||||
| Angel | Jan 19, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Shanghai Refreshgene Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series A Extension, Early Funding |
| Legend Star | Series A, Angel |
| Guangzhou Industrial Investment Holding Group | Series B |
| YuanBio Venture Capital | Series A Extension |
| Guangzhou Science and Technology Financial Innovation Investment Holding | Series B |
| Sinovation Ventures | Series A Extension |
| Legend Holdings | Angel |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 2002% MoM, from 45 to 946.
- Dec 30, 2024
Led by Guangzhou Industrial Investment Holding Group.
For institutional investors. Book with your work email.
Shanghai Refreshgene Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai Refreshgene Technology Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai Refreshgene Technology Co., Ltd. a public or private company?
Shanghai Refreshgene Technology Co., Ltd. is a private company.
What is the current stock price of Shanghai Refreshgene Technology Co., Ltd.?
Shanghai Refreshgene Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shanghai Refreshgene Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai Refreshgene Technology Co., Ltd. worth (valuation)?
Valuation information for Shanghai Refreshgene Technology Co., Ltd. is not publicly available.
Can I buy Shanghai Refreshgene Technology Co., Ltd. stock?
Shanghai Refreshgene Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai Refreshgene Technology Co., Ltd.'s last funding round?
Shanghai Refreshgene Technology Co., Ltd.'s most recent funding round was Series B on December 30, 2024.
Who are the main investors in Shanghai Refreshgene Technology Co., Ltd.?
Key investors in Shanghai Refreshgene Technology Co., Ltd. include Guangzhou Industrial Investment Holding Group, YuanBio Venture Capital, Guangzhou Yuexiu Industrial Investment Fund Management.
Will Shanghai Refreshgene Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai Refreshgene Technology Co., Ltd..
How can I track Shanghai Refreshgene Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai Refreshgene Technology Co., Ltd.'s shares on secondary markets.